JPRN-UMIN000029988尚未招募2 期
Effect and safety on carteorol for infantile hemangioma - Effect and safety on carteorol for infantile hemangioma
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 35days-old 至 150days-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1 congenital hemangioma, Kasabah-Merritt syndrome 2 hypoglycemia, hypotension, bradycardia (arrhythmia), cardiac function disorder 3 Otehr drug administaraion interacted with carteorol within 14 days 4 history of other therapy foy infantile hemangioma(steroid therapy, laser therapy etc)
研究者
相似试验
已完成
不适用
Efficacy of proplanorol for infantile hemangiomaInfantile HemangiomaJPRN-UMIN000020220Tohoku University Hospital25
撤回
2 期
The Use of Ketorolac in Surgical NeonatesPostoperative Pain Control in Surgical NeonatesNCT01667120Nationwide Children's Hospital6
已完成
不适用
Propranolol therapy for pediatric hemangioma and lymphangiomapediatric hemangioma and lymphangiomaJPRN-UMIN000005990Tohoku University Hospital
招募中
不适用
Propranolol and Von Hippel-Lindau DiseaseHemangioblastoma of CNSVon Hippel-Lindau DiseaseNCT05424016Assistance Publique - Hôpitaux de Paris85
已完成
不适用
Propranolol for infantile hemangiomasInfantile hemangiomasJPRN-UMIN000011944Plastic and Reconstructive Surgery, Keio university, School of medicine30